Low price High quality Thymosin Alpha-1 (TA) 99% Purity CAS 62304-98-7 Peptides Factory Supply

Thymosin alpha 1 α 1 ) is a peptide that treats chronic hepatitis B and enhances immune system responsiveness. thymus increases the secretion of interfer by T cells after antigen or mitogen activation α, interfer γ And the levels of lymphokines such as interleukin-2 and interleukin-3, while increasing the level of lymphokine receptors on the surface of T cells. It is also possible to enhance the mixed lymphocyte response of allogeneic and autologous humans by activating CD4 cells. Thymic peptide α 1 may increase the aggregation of pre NK cells, while interfer can enhance their cytotoxicity. In vivo experiments have shown that thymosin alpha1 can increase the expression level of interleukin-2 receptors in mouse lymphocytes activated by concanavalin A, while also increasing the secretion level of interleukin-2. Current thymic peptides on the market α The synthesis preparation method has a long synthesis cycle and high production cost, which is not conducive to the large-scale production of bivaludine.

What is Thymosin Alpha 1 /Thymalfasin?

Thymosin alpha 1 α 1 ) is a drug peptide that treats chronic hepatitis B and enhances immune system responsiveness. thymus α Stimulating peripheral blood lymphocyte mitogen promotes the maturation of T lymphocytes and increases the secretion of interfer by T cells after antigen or mitogen activation α, interfer γ And the levels of lymphokines such as interleukin-2 and interleukin-3, while increasing the level of lymphokine receptors on the surface of T cells. It is also possible to enhance the mixed lymphocyte response of allogeneic and autologous humans by activating CD4 cells. Thymic peptide α 1 may increase the aggregation of pre NK cells, while interfer can enhance their cytotoxicity. In vivo experiments have shown that thymosin alpha1 can increase the expression level of interleukin-2 receptors in mouse lymphocytes activated by concanavalin A, while also increasing the secretion level of interleukin-2. Current thymic peptides on the market α The synthesis preparation method has a long synthesis cycle and high production cost, which is not conducive to the large-scale production of bivaludine.

These products are APIs (Active Pharmaceutical Ingredient) and not a finished drug. 

It is intended strictly for research and laboratory use only.

Buyers are required to fully comply with all applicable laws and regulations regarding the handling and use of this material.

Our Advantage

1. Ultra-High Purity
Each batch is synthesized and purified to >99% purity (HPLC), ensuring reliable and reproducible results in sensitive experiments.

2.Accurate Dosing & Consistency
Our peptides are precisely weighed and vacuum-sealed under sterile conditions. Batch-to-batch consistency is rigorously maintained.

3.Endotoxin-Free & Sterile Processing
Manufactured in a cleanroom environment, our peptides are free from endotoxins, microbial contamination, and other impurities that could interfere with cell-based or in vivo studies.